Efficacy of therapeutic intervention with NanoBEO to manage agitation and pain in patients suffering from severe dementia: a pilot clinical trial.

3.3 Efficacy on pain The patients allocated to the NanoBEO group presented with higher pain intensity at baseline than the patients in the placebo group, as assessed by the I-MOBID2 scores, although this trend did not reach statistical significance ( Figures 6A–C ).

also in 111,027 other papers